<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>WSJ.com: World News - bigTop stories</title>
  <id>https://std-move.github.io/rss-fetcher/wsj-world-bigtop.xml</id>
  <updated>2023-04-10T20:11:43Z</updated>
  <subtitle>World News</subtitle>
  <link href="https://std-move.github.io/rss-fetcher/wsj-world-bigtop.xml"></link>
  <entry>
    <title>Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis</title>
    <updated>2023-04-10T17:49:00Z</updated>
    <id>tag:www.wsj.com,2023-04-10:/articles/ozempic-wegovy-mounjaro-weight-loss-industry-89419ecb</id>
    <content type="html">Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs.</content>
    <link href="https://www.wsj.com/articles/ozempic-wegovy-mounjaro-weight-loss-industry-89419ecb" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>